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Background: Endothelial dysfunction is a risk factor for subsequent coronary events in patients with coronary artery disease (CAD). Its relationship 
to CAD in asymptomatic subjects has not been investigated. We examined the association between endothelial dysfunction and silent ischemia 
among discordant pairs in a twin study.
Methods: We examined 381 male twins aged 47 to 61 years, free of symptomatic CAD from the Vietnam Era Twin (VET) Registry. Subclinical 
ischemia was diagnosed by [13N] ammonia positron emission tomography (PET) at rest and after adenosine stress. A perfusion defect score 
quantified defects in 20 regions. Endothelial function was measured by ultrasound evaluation of brachial artery flow-mediated dilation (FMD). 
Generalized estimating equations (GEE) and fixed models were used for analysis.
Results: Hypertension was present in 33% of the subjects; hyperlipidemia in 37%; diabetes in 9%; 27% of subjects were smokers and 41% obese. 
Myocardial perfusion defects were found in 174 (40%); most (69%) were reversible, indicating subclinical ischemia. There was an inverse correlation 
between FMD and the reversible perfusion defect score (Spearman r = - 0.13, p=0.01) but not the fixed defect score (r= 0.021 p=0.67). From the 
lowest to the highest quartile of FMD, the prevalence of reversible defects was 14%, 25%, 30%, 33% p=0.002. In multivariable analysis adjusting 
for CAD risk factors, the probability of reversible defects increased 17 % (95% CI, 5%-30%, p=.003) for each quartile of decreasing FMD. In 57 twin 
pairs discordant for reversible perfusion defects, twins with defects were two times more likely to have abnormal FMD (<7% dilation) than their co-
twins without defects (p=.05).
Conclusions: In our study of middle aged twins, endothelial dysfunction is an independent predictor of silent ischemia. Since it persists within twin 
pairs, this relationship is not confounded by genetic or shared environmental factors.
